These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19525498)

  • 1. Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators.
    ; Vijgen J; Botto G; Camm J; Hoijer CJ; Jung W; Le Heuzey JY; Lubinski A; Norekvål TM; Santomauro M; Schalij M; Schmid JP; Vardas P
    Europace; 2009 Aug; 11(8):1097-107. PubMed ID: 19525498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators.
    Vijgen J; Botto G; Camm J; Hoijer CJ; Jung W; Le Heuzey JY; Lubinski A; Norekvål TM; Santomauro M; Schalij M; Schmid JP; Vardas P
    Eur J Cardiovasc Nurs; 2010 Mar; 9(1):3-14. PubMed ID: 20170847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it safe to allow patients with implantable cardioverter-defibrillators to drive? Learnings from a single center experience.
    Curnis A; Mascioli G; Bontempi L; Cerini M; Bignotti T; Bonetti G; Dei Cas L
    J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1241-5. PubMed ID: 19001931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Driving restrictions for arrhythmia patients--with special reference to the implantable cardioverter/defibrillator].
    Lüderitz B; Jung W
    Z Kardiol; 1996; 85 Suppl 6():115-21. PubMed ID: 9064955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addendum to "Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology": public safety issues in patients with implantable defibrillators: a scientific statement from the American Heart Association and the Heart Rhythm Society.
    Epstein AE; Baessler CA; Curtis AB; Estes NA; Gersh BJ; Grubb B; Mitchell LB; ;
    Circulation; 2007 Mar; 115(9):1170-6. PubMed ID: 17287391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Driving of a motor vehicle after implantation of a cardioverter-defibrillator in malignant heart rhythm disorders. Criteria for the medical assessment of driving fitness in Europe].
    Lüderitz B; Jung W
    Dtsch Med Wochenschr; 1996 Feb; 121(5):119-23. PubMed ID: 8717193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Restrictions for ICD patients in daily life].
    Köbe J; Gradaus R; Zumhagen S; Böcker D
    Herz; 2005 Nov; 30(7):625-9. PubMed ID: 16333589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences of driving and driving restrictions in recipients with an implantable cardioverter defibrillator--the patient perspective.
    Johansson I; Strömberg A
    J Cardiovasc Nurs; 2010; 25(6):E1-E10. PubMed ID: 20938245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Automobile driving and implantable defibrillators].
    Lerecouvreux M; Aït Saïd M; Paziaud O; Perrier E; Carlioz R; Lavergne T; Guize L; Le Heuzey JY
    Arch Mal Coeur Vaiss; 2005 Apr; 98(4):288-93. PubMed ID: 15881843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fitness to drive in patients with implanted cardioverter-defibrillator].
    Klein HH
    Dtsch Med Wochenschr; 2012 Sep; 137(39):1927-30. PubMed ID: 22996581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines of the Spanish Society of Cardiology for car driving, airplane flying,and underwater activities in subjects with heart disease].
    García-Cosío Mir F; Alberca Vela T; Rubio Sanz J; Grande Ruiz A; Viqueira Caamaño JA; Curcio Ruigómez A; Navarro Ruiz V;
    Rev Esp Cardiol; 2001 Apr; 54(4):476-90. PubMed ID: 11282053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate implantable cardioverter defibrillator shocks-incidence, effect, and implications for driver licensing.
    Watanabe E; Okajima K; Shimane A; Ozawa T; Manaka T; Morishima I; Asai T; Takagi M; Honda T; Kasai A; Fujii E; Yamashiro K; Kohno R; Abe H; Noda T; Kurita T; Watanabe S; Ohmori H; Nitta T; Aizawa Y; Kiyono K; Okumura K
    J Interv Card Electrophysiol; 2017 Sep; 49(3):271-280. PubMed ID: 28730420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effect of implantable cardioverter defibrillator replacements: when should you resume driving after an implantable cardioverter defibrillator replacement?
    Kawata H; Noda T; Kurita T; Yamagata K; Yamada Y; Okamura H; Satomi K; Shimizu W; Suyama K; Aihara N; Isobe M; Kamakura S
    Circ J; 2010 Nov; 74(11):2301-7. PubMed ID: 20877125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The implantable defibrillator and return to operation of vehicles study.
    Mylotte D; Sheahan RG; Nolan PG; Neylon MA; McArdle B; Constant O; Diffley A; Keane D; Nash PJ; Crowley J; Daly K
    Europace; 2013 Feb; 15(2):212-8. PubMed ID: 22968849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to resumption of driving after implantation of an automatic defibrillator (from the Dual chamber and VVI Implantable Defibrillator [DAVID] trial).
    Baessler C; Murphy S; Gebhardt L; Tso T; Ellenbogen K; Leman R;
    Am J Cardiol; 2005 Mar; 95(5):665-6. PubMed ID: 15721116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on 'ICD and Driving' of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology.
    Jung W; Anderson M; Camm AJ; Jordaens L; Petch MC; Rosenqvist M; Santini M; Lüderitz B
    Eur Heart J; 1997 Aug; 18(8):1210-9. PubMed ID: 9458413
    [No Abstract]   [Full Text] [Related]  

  • 17. Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations.
    Imberti JF; Vitolo M; Proietti M; Diemberger I; Ziacchi M; Biffi M; Boriani G
    Expert Rev Med Devices; 2020 Apr; 17(4):297-308. PubMed ID: 32160800
    [No Abstract]   [Full Text] [Related]  

  • 18. Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: implications of international guidelines.
    Foley PW; Addison CE; Whinney SB; Patel K; Cunningham D; Frenneaux MP; Leyva F
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S131-4. PubMed ID: 19250076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived and actual risks of driving in patients with arrhythmia control devices.
    Beauregard LA; Barnard PW; Russo AM; Waxman HL
    Arch Intern Med; 1995 Mar; 155(6):609-13. PubMed ID: 7887756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time Course of Subsequent Shocks After Initial Implantable Cardioverter-Defibrillator Discharge and Implications for Driving Restrictions.
    Merchant FM; Hoskins MH; Benser ME; Roberts G; Bastek AN; Knezevic A; Huang Y; Langberg JJ; Leon AR; El-Chami MF
    JAMA Cardiol; 2016 May; 1(2):181-8. PubMed ID: 27437889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.